Hemostasis, Thrombosis, and Vascular Biology

Sprouting angiogenesis is critical to blood vessel formation, but the cellular and molecular controls of this process are poorly understood. We used time-lapse imaging of green fluorescent protein (GFP)-expressing vessels derived from stem cells to analyze dynamic aspects of vascular sprout formation and to determine how the vascular endothelial growth factor (VEGF) receptor flt-1 affects sprouting. Surprisingly, loss of flt-1 led to decreased sprout formation and migration, which resulted in reduced vascular branching. This phenotype was also seen in vivo, as flt-1 -/- embryos had defective sprouting from the dorsal aorta. We previously showed that loss of flt-1 increases the rate of endothelial cell division. However, the timing of division versus morphogenetic effects suggested that these phenotypes were not causally linked, and in fact mitoses were prevalent in the sprout field of both wild-type and flt-1 -/- mutant vessels. Rather, rescue of the branching defect by a soluble flt-1 (sflt-1) transgene supports a model whereby flt-1 normally positively regulates sprout formation by production of sflt-1, a soluble form of the receptor that antagonizes VEGF signaling. Thus precise levels of bioactive VEGF-A and perhaps spatial localization of the VEGF signal are likely modulated by flt-1 to ensure proper sprout formation during blood vessel formation. (Blood. 2004;103:4527-4535)

[1]  Rakesh Kumar,et al.  The vascular endothelial growth factor (VEGF) receptor Flt-1 (VEGFR-1) modulates Flk-1 (VEGFR-2) signaling during blood vessel formation. , 2004, The American journal of pathology.

[2]  L. Claesson‐Welsh,et al.  VEGF receptor signal transduction. , 2003, Science's STKE : signal transduction knowledge environment.

[3]  K. Alitalo,et al.  VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia , 2003, The Journal of cell biology.

[4]  V. V. van Hinsbergh,et al.  Involvement of RhoA/Rho Kinase Signaling in VEGF-Induced Endothelial Cell Migration and Angiogenesis In Vitro , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[5]  A. Hall,et al.  Rho GTPases in cell biology , 2002, Nature.

[6]  D. Mukhopadhyay,et al.  KDR Stimulates Endothelial Cell Migration through Heterotrimeric G Protein Gq/11-mediated Activation of a Small GTPase RhoA* , 2002, The Journal of Biological Chemistry.

[7]  Holger Gerhardt,et al.  Spatially restricted patterning cues provided by heparin-binding VEGF-A control blood vessel branching morphogenesis. , 2002, Genes & development.

[8]  A. Nagy,et al.  Insufficient VEGFA activity in yolk sac endoderm compromises haematopoietic and endothelial differentiation. , 2002, Development.

[9]  Joseph B. Kearney,et al.  Vascular endothelial growth factor receptor Flt-1 negatively regulates developmental blood vessel formation by modulating endothelial cell division. , 2002, Blood.

[10]  Ingeborg Stalmans,et al.  Arteriolar and venular patterning in retinas of mice selectively expressing VEGF isoforms. , 2002, The Journal of clinical investigation.

[11]  A. Ridley,et al.  Rho family proteins: coordinating cell responses. , 2001, Trends in cell biology.

[12]  I. Zachary,et al.  Src mediates stimulation by vascular endothelial growth factor of the phosphorylation of focal adhesion kinase at tyrosine 861, and migration and anti-apoptosis in endothelial cells. , 2001, The Biochemical journal.

[13]  J. Gurdon,et al.  Morphogen gradient interpretation , 2001, Nature.

[14]  B. Bussolati,et al.  Vascular endothelial growth factor receptor-1 modulates vascular endothelial growth factor-mediated angiogenesis via nitric oxide. , 2001, The American journal of pathology.

[15]  D. Mukhopadhyay,et al.  Vascular Permeability Factor (VPF)/Vascular Endothelial Growth Factor (VEGF) Receptor-1 Down-modulates VPF/VEGF Receptor-2-mediated Endothelial Cell Proliferation, but Not Migration, through Phosphatidylinositol 3-Kinase-dependent Pathways* , 2001, The Journal of Biological Chemistry.

[16]  Keith Burridge,et al.  RhoA is required for monocyte tail retraction during transendothelial migration , 2001, The Journal of cell biology.

[17]  N. Ferrara,et al.  Analysis of Biological Effects and Signaling Properties of Flt-1 (VEGFR-1) and KDR (VEGFR-2) , 2001, The Journal of Biological Chemistry.

[18]  H. Farber,et al.  VEGF is deposited in the subepithelial matrix at the leading edge of branching airways and stimulates neovascularization in the murine embryonic lung , 2000, Developmental dynamics : an official publication of the American Association of Anatomists.

[19]  M. Schwartz,et al.  Focal adhesion kinase suppresses Rho activity to promote focal adhesion turnover. , 2000, Journal of cell science.

[20]  A. Nagy,et al.  Embryonic development is disrupted by modest increases in vascular endothelial growth factor gene expression. , 2000, Development.

[21]  N. Rahimi,et al.  Receptor Chimeras Indicate That the Vascular Endothelial Growth Factor Receptor-1 (VEGFR-1) Modulates Mitogenic Activity of VEGFR-2 in Endothelial Cells* , 2000, The Journal of Biological Chemistry.

[22]  K. Shitara,et al.  Roles of two VEGF receptors, Flt-1 and KDR, in the signal transduction of VEGF effects in human vascular endothelial cells , 2000, Oncogene.

[23]  Jacques Landry,et al.  Vascular Endothelial Growth Factor (VEGF)-driven Actin-based Motility Is Mediated by VEGFR2 and Requires Concerted Activation of Stress-activated Protein Kinase 2 (SAPK2/p38) and Geldanamycin-sensitive Phosphorylation of Focal Adhesion Kinase* , 2000, The Journal of Biological Chemistry.

[24]  P. Carmeliet,et al.  Characterization of the vasculogenic block in the absence of vascular endothelial growth factor-A. , 2000, Blood.

[25]  Mikyoung Park,et al.  The fourth immunoglobulin-like loop in the extracellular domain of FLT-1, a VEGF receptor, includes a major heparin-binding site. , 1999, Biochemical and biophysical research communications.

[26]  S. Soker,et al.  Vascular Endothelial Growth Factor Effect on Endothelial Cell Proliferation, Migration, and Platelet-activating Factor Synthesis Is Flk-1-dependent* , 1999, The Journal of Biological Chemistry.

[27]  J. Peng,et al.  Increased hemangioblast commitment, not vascular disorganization, is the primary defect in flt-1 knock-out mice. , 1999, Development.

[28]  M. Krasnow,et al.  Genetic control of branching morphogenesis. , 1999, Science.

[29]  S. Redick,et al.  Developmental platelet endothelial cell adhesion molecule expression suggests multiple roles for a vascular adhesion molecule. , 1999, The American journal of pathology.

[30]  M. Bryckaert,et al.  Fibroblast growth factor (FGF) soluble receptor 1 acts as a natural inhibitor of FGF2 neurotrophic activity during retinal degeneration. , 1998, Molecular biology of the cell.

[31]  C. Little,et al.  Morphogenesis of the First Blood Vessels , 1998, Annals of the New York Academy of Sciences.

[32]  C. Wernstedt,et al.  Identification of Vascular Endothelial Growth Factor Receptor-1 Tyrosine Phosphorylation Sites and Binding of SH2 Domain-containing Molecules* , 1998, The Journal of Biological Chemistry.

[33]  T. Noda,et al.  Flt-1 lacking the tyrosine kinase domain is sufficient for normal development and angiogenesis in mice. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[34]  Janet Rossant,et al.  A Requirement for Flk1 in Primitive and Definitive Hematopoiesis and Vasculogenesis , 1997, Cell.

[35]  I. Zachary,et al.  Vascular Endothelial Growth Factor Stimulates Tyrosine Phosphorylation and Recruitment to New Focal Adhesions of Focal Adhesion Kinase and Paxillin in Endothelial Cells* , 1997, The Journal of Biological Chemistry.

[36]  W. Risau,et al.  Mechanisms of angiogenesis , 1997, Nature.

[37]  R. Moon,et al.  Structurally Related Receptors and Antagonists Compete for Secreted Wnt Ligands , 1997, Cell.

[38]  R. Kendall,et al.  Identification of a natural soluble form of the vascular endothelial growth factor receptor, FLT-1, and its heterodimerization with KDR. , 1996, Biochemical and biophysical research communications.

[39]  Lieve Moons,et al.  Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele , 1996, Nature.

[40]  Kenneth J. Hillan,et al.  Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene , 1996, Nature.

[41]  V L Bautch,et al.  Blood island formation in attached cultures of murine embryonic stem cells , 1996, Developmental dynamics : an official publication of the American Association of Anatomists.

[42]  G. Breier,et al.  Coordinate expression of vascular endothelial growth factor receptor‐1 (fit‐1) and its ligand suggests a paracrine regulation of murine vascular development , 1995, Developmental dynamics : an official publication of the American Association of Anatomists.

[43]  C. Little,et al.  Exogenous vascular endothelial growth factor induces malformed and hyperfused vessels during embryonic neovascularization. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[44]  J. Rossant,et al.  Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium , 1995, Nature.

[45]  M. Shibuya,et al.  Different signal transduction properties of KDR and Flt1, two receptors for vascular endothelial growth factor. , 1994, The Journal of biological chemistry.

[46]  N. Ling,et al.  Identification of soluble forms of the fibroblast growth factor receptor in blood. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[47]  J. Park,et al.  The vascular endothelial growth factor (VEGF) isoforms: differential deposition into the subepithelial extracellular matrix and bioactivity of extracellular matrix-bound VEGF. , 1993, Molecular biology of the cell.

[48]  R. Kendall,et al.  Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[49]  J. Folkman,et al.  Migration and proliferation of endothelial cells in preformed and newly formed blood vessels during tumor angiogenesis. , 1977, Microvascular research.

[50]  Eliot R. Clark,et al.  Microscopic observations on the growth of blood capillaries in the living mammal , 1939 .

[51]  G. Martiny-Baron,et al.  Identification of a soluble form of the angiopoietin receptor TIE-2 released from endothelial cells and present in human blood , 2004, Angiogenesis.

[52]  Joseph B. Kearney,et al.  In vitro differentiation of mouse ES cells: hematopoietic and vascular development. , 2003, Methods in enzymology.

[53]  D. Abrahamson,et al.  Endothelial signal integration in vascular assembly. , 2000, Annual review of physiology.

[54]  F. Sabin Studies on the origin of blood vessels and of red corpuscles as seen in the living blastoderm of the chick during the second day of incubation , 1920 .